Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Available and Future Pharmaceutical Options
Emmanouil Koullias(National and Kapodistrian University of Athens), Anastasia Thanopoulou(National and Kapodistrian University of Athens), Melanie Deutsch(National and Kapodistrian University of Athens), John Koskinas(National and Kapodistrian University of Athens), Maria Papavdi(National and Kapodistrian University of Athens)
Cited by 6
Related Papers
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
|Nutrients|2019|475
Global dietary quality in 185 countries from 1990 to 2018 show wide differences by nation, age, education, and urbanicity
|Nature Food|2022|254
Evidence-based European recommendations for the dietary management of diabetes
|Diabetologia|2023|254
Relation of the Mediterranean diet with the incidence of gestational diabetes
|European Journal of Clinical Nutrition|2013|195
Incident type 2 diabetes attributable to suboptimal diet in 184 countries
|Nature Medicine|2023|193